RNAC earnings: a positive outcome, +9.5%

On March 12, 2021, Cartesian Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +9.5% in the window around the event. It had already run -16.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.